CYCS
protein-codingcytochrome c, somatic
Gene summary
This gene encodes a small heme protein that functions as a central component of the electron transport chain in mitochondria. The encoded protein associates with the inner membrane of the mitochondrion where it accepts electrons from cytochrome b and transfers them to the cytochrome oxidase complex. This protein is also involved in initiation of apoptosis. Mutations in this gene are associated with autosomal dominant nonsyndromic thrombocytopenia. Numerous processed pseudogenes of this gene are found throughout the human genome.[provided by RefSeq, Jul 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~6.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0012775
Submitter: ClinGen
CYCS was first reported in relation to autosomal dominant thrombocytopenia 4 in 2008 (Morison IM, et al., PMID: 18345000). At least 15 unique variants (14 missense and 1 small in-frame deletion) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and segregation data. Variants in this gene have been reported in at least 26 probands in 9 publications (PMIDs: 18345000, 2432610, 27479822, 30051457, 31064749, 32581362, 35126455, 36507135, 34355501) and one ClinVar entry (SCV004104803.1). Variants in this gene segregated with disease in at least 34 additional family members. Experimental evidence of a functional alteration of platelet formation (PMID: 27861742) was shown in patient cells, however the normal function of CYCS in relation to platelet formation remains unclear. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This gene-disease pair was originally evaluated by the HT GCEP on 2021 Jun 23. It was reevaluated on 2025 Jan 23. As a result of this reevaluation 11 additional patients were identified (PMIDs: 35126455, 36507135, 34355501, SCV004104803.1) however the classification remained Limited.
Inheritance Pattern: AD
Disease ID:MONDO:0012775
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0015679
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0012775
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Hematologic
Intervention: General
Rationale: Reported clinical findings related to thrombocytopenia were absent or mild; Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CYCS variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018947.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 13 | ||||
| missense | 1 | 7 | 23 | 31 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 1 | 7 | 24 | 13 | 0 | 45 |
Highest pathogenic variant AF is 0.0000013681014
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_061820.1 | 2 | MANE Select | |
| Ensembl | ENSP00000307786.2 | 2 | MANE Select | |
| Ensembl | ENSP00000386270.1 | 2 | Standard | |
| Ensembl | ENSP00000386270.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Kaposi,s sarcoma-associated herpesvirus infection - Homo sapiens (human)
- Legionellosis - Homo sapiens (human)
- Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human)
- Viral myocarditis - Homo sapiens (human)
- p53 signaling pathway - Homo sapiens (human)
Biological Process
- mitochondrial electron transport, ubiquinol to cytochrome c
- mitochondrial electron transport, cytochrome c to oxygen
- protein dephosphorylation
- mitochondrion organization
- activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c
Molecular Function
- protein serine/threonine phosphatase activity
- protein binding
- heme binding
- electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity
- metal ion binding
Cellular Component
- protein phosphatase type 2A complex
- nucleus
- mitochondrion
- mitochondrial inner membrane
- mitochondrial intermembrane space
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000305786
- Coding exons
- 2
- Length
- 5271
- Individuals with no LoFs
- 125640
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 125641
- p
- 0.00000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.18 | 30 | 54.6 | 0.549 | 0.00000277 | 692 |
| Missense (PolyPhen) | 0 | 5.4301 | 0 | 81 | ||
| Synonymous | -1.07 | 26 | 19.9 | 1.31 | 0.00000113 | 187 |
| Loss of Function | 1.67 | 0 | 3.25 | 0.00 | 1.38e-7 | 51 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0000088 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Electron carrier protein. The oxidized form of the cytochrome c heme group can accept an electron from the heme group of the cytochrome c1 subunit of cytochrome reductase. Cytochrome c then transfers this electron to the cytochrome oxidase complex, the final protein carrier in the mitochondrial electron-transport chain.;
- Disease
- DISEASE: Thrombocytopenia 4 (THC4) [MIM:612004]: Thrombocytopenia is defined by a decrease in the number of platelets in circulating blood, resulting in the potential for increased bleeding and decreased ability for clotting. {ECO:0000269|PubMed:18345000}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.988
Intolerance Scores
- RVIS EVS
- 0.08
- RVIS percentile EVS
- 59.43
Essentials
- Essential (CRISPR)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.998
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |